Managed care
Bella Vista Medical Group Ipa
Bella Vista Medical Group Ipa was paid $108K by Medicaid between Jan 2018 and Aug 2021, across 99 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoBELLA VISTA MEDICAL GROUP IPA
WOODLAND HILLS, CA 91367
WOODLAND HILLS, CA 91367
33aNPI1093844656assigned 03/02/2007
33bProvider typeHealth Maintenance Organization
28Total paid$108K
24GClaims41,021
24DCodes billed99
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#67 of 151
Median peer was paid$59K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,543 | $89K | |
| 2020 | 3,193 | $8K | |
| 2021 | 5,285 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 6,577 | 5,738 | $30K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 697 | 625 | $13K |
| S9083 | Global fee urgent care centers | 7.9% | 207 | 194 | $9K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.0% | 150 | 148 | $6K |
| 90710 | 5.8% | 46 | 44 | $6K | |
| 90651 | 5.0% | 71 | 70 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.2% | 556 | 543 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 210 | 210 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.8% | 32 | 32 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 216 | 216 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.3% | 562 | 549 | $3K |
| 99223 | Prolong inpt eval add15 m | 2.0% | 15 | 14 | $2K |
87 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 47 | $2K |
| 99285 | Emergency room visit (most serious) | 1.4% | 15 | $2K |
| 92552 | 1.4% | 390 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 1,924 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 12 | $1K |
| 85018 | 1.0% | 681 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 3008F | <1% | 1,453 | $928.85 | |
| 99173 | <1% | 439 | $855.12 | |
| 81002 | <1% | 320 | $837.88 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,134 | $802.12 |
| 99283 | Emergency room visit (moderate) | <1% | 14 | $745.07 |
| 3074F | <1% | 1,859 | $740.53 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 95 | $734.78 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 18 | $720.00 |
| 80061 | Lipid panel | <1% | 1,838 | $626.18 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 146 | $618.35 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,563 | $533.49 |
| 3078F | <1% | 2,838 | $488.91 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 841 | $381.00 |
| 92133 | <1% | 15 | $278.17 | |
| 92250 | <1% | 15 | $271.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,358 | $225.89 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 17 | $196.80 |
| 3075F | <1% | 1,054 | $180.23 | |
| 92083 | <1% | 15 | $156.03 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 43 | $150.00 |
| 81000 | <1% | 237 | $108.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,566 | $99.48 |
| 90688 | <1% | 27 | $98.14 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 59 | $91.64 |
| 86580 | <1% | 33 | $72.55 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 630 | $68.56 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 175 | $63.08 |
| 82962 | <1% | 101 | $57.40 | |
| 1159F | <1% | 90 | $57.30 | |
| 85730 | <1% | 61 | $55.85 | |
| 85610 | <1% | 57 | $50.92 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 34 | $50.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 228 | $46.88 |
| 83690 | <1% | 13 | $25.77 | |
| 3079F | <1% | 216 | $23.87 | |
| 1160F | <1% | 88 | $23.49 | |
| 81001 | <1% | 695 | $10.97 | |
| 86592 | <1% | 762 | $9.58 | |
| 99401 | <1% | 249 | $9.00 | |
| 96150 | <1% | 250 | $9.00 | |
| 3077F | <1% | 274 | $8.08 | |
| 84439 | <1% | 103 | $7.14 | |
| 81003 | <1% | 464 | $6.65 | |
| 99000 | <1% | 163 | $4.86 | |
| 84550 | <1% | 509 | $3.57 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 43 | $1.42 |
| 90656 | <1% | 15 | $1.00 | |
| 82570 | 0% | 318 | $0.00 | |
| 84481 | 0% | 37 | $0.00 | |
| 97803 | 0% | 299 | $0.00 | |
| 3725F | 0% | 142 | $0.00 | |
| 94664 | 0% | 12 | $0.00 | |
| 83655 | 0% | 165 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 30 | $0.00 |
| 90658 | 0% | 23 | $0.00 | |
| 82248 | 0% | 14 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 43 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 12 | $0.00 |
| 90734 | 0% | 13 | $0.00 | |
| 82947 | 0% | 27 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 18 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 12 | $0.00 |
| 82043 | 0% | 298 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 92 | $0.00 |
| 1036F | 0% | 119 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 249 | $0.00 |
| 92499 | 0% | 181 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 95 | $0.00 |
| 84436 | 0% | 603 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 277 | $0.00 |
| 84479 | 0% | 431 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 144 | $0.00 |
| 3080F | 0% | 12 | $0.00 | |
| 92551 | 0% | 210 | $0.00 | |
| 85027 | 0% | 104 | $0.00 | |
| 86803 | 0% | 12 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 250 | $0.00 |
| 84480 | 0% | 105 | $0.00 | |
| 97802 | 0% | 12 | $0.00 | |
| 84153 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEAKTOR, LINDA (DIRECTOR OF MEDICAL AFFAIRS)
| Provider | Location | Paid |
|---|---|---|
| Health Care LA, Ipa | Woodland Hills, CA | $10.89M |
| Global Care Medical Group Ipa | Woodland Hills, CA | $1.86M |
| Mission Community Ipa Medical Group | Woodland Hills, CA | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.